BRCA2 and breast cancer: In addition, Coignard et al. identified two, respectively three, loci that modify BC risks in BRCA1, respectively BRCA2, mutation carriers exclusively, which point towards the need for establishment of divergent PRSs for BRCA1 and BRCA2 PV carriers.